- Home
- XERS vs PEO Comparison
XERS vs PEO Comparison
Compare XERS & PEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- PEO
- Stock Information
- Founded
- XERS 2005
- PEO 1929
- Country
- XERS United States
- PEO United States
- Employees
- XERS N/A
- PEO N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- PEO Finance/Investors Services
- Sector
- XERS Health Care
- PEO Finance
- Exchange
- XERS Nasdaq
- PEO Nasdaq
- Market Cap
- XERS 500.2M
- PEO 551.1M
- IPO Year
- XERS 2018
- PEO N/A
- Fundamental
- Price
- XERS $3.47
- PEO $21.33
- Analyst Decision
- XERS Buy
- PEO
- Analyst Count
- XERS 3
- PEO 0
- Target Price
- XERS $4.87
- PEO N/A
- AVG Volume (30 Days)
- XERS 1.8M
- PEO 35.4K
- Earning Date
- XERS 11-08-2024
- PEO 01-01-0001
- Dividend Yield
- XERS N/A
- PEO 5.93%
- EPS Growth
- XERS N/A
- PEO N/A
- EPS
- XERS N/A
- PEO N/A
- Revenue
- XERS $187,361,000.00
- PEO N/A
- Revenue This Year
- XERS $24.27
- PEO N/A
- Revenue Next Year
- XERS $18.57
- PEO N/A
- P/E Ratio
- XERS N/A
- PEO N/A
- Revenue Growth
- XERS 22.72
- PEO N/A
- 52 Week Low
- XERS $1.69
- PEO $19.22
- 52 Week High
- XERS $3.87
- PEO $23.80
- Technical
- Relative Strength Index (RSI)
- XERS 54.75
- PEO 26.99
- Support Level
- XERS $3.32
- PEO $20.90
- Resistance Level
- XERS $3.57
- PEO $21.83
- Average True Range (ATR)
- XERS 0.18
- PEO 0.37
- MACD
- XERS -0.01
- PEO -0.12
- Stochastic Oscillator
- XERS 42.86
- PEO 18.61
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.
About PEO Adams Natural Resources Fund Inc.
Adams Natural Resources Fund Inc is a closed-end equity investment company specializing in energy and other natural resources stocks. The investment objectives of the fund are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. Its portfolio of investments comprises of different sector investments such as in the energy sector and basic materials.